DPYSL2 and amyotrophic lateral sclerosis: In addition, crossing CRMP2KI with SOD1G39A, a model of ALS, improved this pathology(Numata-Uematsu et al., 2019), suggesting that the suppression of CRMP2 phosphorylation may lead to pathological improvement in other neurodegenerative diseases.